BA-10-WH12_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, N-[5-(1-methylcyclopropyl)-1H-pyrazol-3-yl]-5-(5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yloxy)indole-1-carboxamide, VEGFR-2 (FLK-1/KDR) Inhibitors targeting KDR (Novartis, 56970466)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/56970466
Similar Terms
Downloads & Tools

Genes

15 genes differentially expressed following the BA-10-WH12_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FKBP1A FK506 binding protein 1A, 12kDa 2.0144
CIB1 calcium and integrin binding 1 (calmyrin) 1.95159
UCK2 uridine-cytidine kinase 2 0.86946
SERP1 stress-associated endoplasmic reticulum protein 1 0.762773
VAPA VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa 0.605586
RPL37 ribosomal protein L37 0.543268
PGP phosphoglycolate phosphatase 0.502001
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.37322
NAA10 N(alpha)-acetyltransferase 10, NatA catalytic subunit 0.368352
CDC20 cell division cycle 20 0.367335
MYL1 myosin, light chain 1, alkali; skeletal, fast 0.33979
RUVBL1 RuvB-like AAA ATPase 1 0.209426

decreased expression

Symbol Name Standardized Value
NFATC1 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 -0.287703
MAGED1 melanoma antigen family D1 -0.235134
ZNF280D zinc finger protein 280D -0.235134